Beth Valmassoi
Adult Health · Royal Oak, MINPI 1629131644
Payments from drug & device makers
Across 80 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$263
- Boehringer Ingelheim$194
- Ardelyx, Inc.$180
- Aurinia Pharma U.S., Inc.$168
- AstraZeneca$154
- Travere Therapeutics, Inc.$124
- plus $756 from 14 others
What the payments were for
- Food & beverage$1,75095%
- Education$895%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $263 |
| Boehringer Ingelheim | 4 | $194 |
| Ardelyx, Inc. | 4 | $180 |
| Aurinia Pharma U.S., Inc. | 8 | $168 |
| AstraZeneca(2 entities) | 9 | $154 |
| Travere Therapeutics, Inc. | 7 | $124 |
| Bayer | 5 | $97 |
| OPKO Pharmaceuticals, LLC | 5 | $89 |
| Novartis | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| ANI Pharmaceuticals, Inc. | 3 | $61 |
| Mallinckrodt Hospital Products Inc. | 3 | $60 |
| Fresenius USA Marketing, Inc. | 3 | $56 |
| Calliditas Therapeutics US Inc. | 2 | $50 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Vifor Pharma, Inc. | 2 | $45 |
| Ultragenyx Pharmaceutical Inc. | 2 | $31 |
| Cormedix Inc. | 1 | $27 |
| Amgen | 1 | $16 |
| Akebia Therapeutics Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JYNARQUE$124
- JARDIANCE$122
- XPHOZAH 30 MG$113
How this compares
$1,839 in reported general payments places this provider in the 80th percentile of 527 adult health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $44,636 |
| FarxigaDapagliflozin Propanediol | 24 | $21,564 |
| Sevelamer Carbonate | 26 | $3,591 |
| Calcitriol | 146 | $2,937 |
| Calcium Acetate | 23 | $2,845 |
| Bumetanide | 66 | $2,385 |
| Valsartan | 20 | $994 |
| Carvedilol | 42 | $774 |
| Amlodipine Besylate | 55 | $640 |
| Nifedipine ErNifedipine | 17 | $613 |
| Losartan Potassium | 41 | $577 |
| Allopurinol | 27 | $494 |
| Spironolactone | 37 | $464 |
| Atorvastatin Calcium | 20 | $391 |
| Minoxidil | 12 | $329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $194 | $44,63639 claims |
| AstraZenecaFarxiga | $154 | $21,56424 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $61 | $99420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 527 adult health providers in Michigan.
Other adult health in Royal Oak
- Jacqueline BrewerSterling Heights$138K
- Linda Morris McCoyGrand Rapids$59K
- Sarita RaoCanton$51K
- Susanne QuallichAnn Arbor$42K
- Nancy BermanSouthfield$39K
- Michelle MillerQuincy$24K
- Deniene KingAnn Arbor$14K
- Adama JohnsonEastpointe$14K
- Bridget BonelloWyandotte$13K
- Mary KaiserKalamazoo$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.